Controlling distinct signaling states in cultured cancer cells provides a new platform for drug discovery

Steven W. Poser, Oliver Otto, Carina Arps‐Forker, Yan Ge, Maik Herbig, Cordula Andree, Konrad Gruetzmann, Melissa F. Adasme, Szymon Stodolak, Polyxeni Nikolakopoulou, Deric M. Park, Alan Mcintyre, Mathias Lesche, Andreas Dahl, Petra Lennig, Stefan R. Bornstein, Evelin Schroeck, Barbara Klink, Ronen R. Leker, Marc Bickle, George P. Chrousos, Michael Schroeder, Carlo Vittorio Cannistraci, Jochen Guck, Andreas Androutsellis‐Theotokis

FASEB j. 33(8):9235–9249 May 30, 2019

DOI: 10.1096/fj.201802603rr